HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria A Cavasin Selected Research

Pulmonary Hypertension

1/2021DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
2/2017Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
3/2015Emerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series).
3/2012Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria A Cavasin Research Topics

Disease

16Fibrosis (Cirrhosis)
01/2023 - 08/2002
9Heart Failure
01/2023 - 08/2002
7Myocardial Infarction
01/2019 - 05/2003
6Hypertension (High Blood Pressure)
01/2023 - 03/2004
6Cardiomegaly (Heart Hypertrophy)
01/2021 - 09/2007
6Hypertrophy
01/2021 - 03/2004
5Infarction (Infarctions)
01/2019 - 02/2004
5Heart Rupture
05/2006 - 05/2003
4Pulmonary Hypertension
01/2021 - 03/2012
4Hypoxia (Hypoxemia)
02/2017 - 03/2012
3Vascular Remodeling
01/2021 - 03/2012
3Right Ventricular Hypertrophy
10/2017 - 03/2012
3Inflammation (Inflammations)
08/2008 - 01/2006
2Heart Diseases (Heart Disease)
01/2022 - 10/2017
2Cardiovascular Diseases (Cardiovascular Disease)
06/2014 - 07/2011
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
02/2021
1Mental Disorders (Mental Disorder)
05/2020
1Left Ventricular Dysfunction
01/2018
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2016
1Ventricular Remodeling
03/2015
1Pulmonary Arterial Hypertension
11/2014
1Vascular Diseases (Vascular Disease)
06/2014
1Chronic Renal Insufficiency
06/2014
1Atherosclerosis
06/2014
1Vascular Calcification
06/2014
1Renal Insufficiency (Renal Failure)
02/2014

Drug/Important Bio-Agent (IBA)

6Angiotensin IIIBA
01/2023 - 07/2007
6Histone Deacetylases (Histone Deacetylase)IBA
02/2021 - 07/2011
6Histone Deacetylase InhibitorsIBA
01/2018 - 07/2011
5Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2007
5Protein Isoforms (Isoforms)IBA
01/2018 - 07/2011
4goralatideIBA
07/2007 - 03/2004
3Vasodilator Agents (Vasodilators)IBA
02/2017 - 03/2012
3Estrogens (Estrogen)FDA Link
06/2013 - 05/2003
3CollagenIBA
07/2007 - 03/2004
2EnzymesIBA
01/2023 - 02/2017
2salicylhydroxamic acid (SHAM)IBA
12/2022 - 09/2007
2ConnectinIBA
01/2022 - 01/2018
2givinostat hydrochlorideIBA
02/2021 - 01/2018
2Peptide Hormones (Polypeptide Hormones)IBA
01/2021 - 07/2014
2Carrier Proteins (Binding Protein)IBA
01/2019 - 10/2013
2Histones (Histone)IBA
01/2019 - 06/2013
2Tadalafil (Cialis)FDA Link
02/2017 - 03/2012
2Atrial Natriuretic Factor (ANF)IBA
01/2016 - 10/2013
2Endothelin Receptor AntagonistsIBA
11/2014 - 08/2002
2Endothelin-1 (Endothelin 1)IBA
06/2010 - 08/2002
2Testosterone (Sustanon)FDA Link
05/2006 - 05/2003
2Matrix Metalloproteinases (MMPs)IBA
09/2004 - 02/2004
1Acetates (Acetic Acid Esters)FDA Link
01/2023
115-hydroxyprostaglandin dehydrogenaseIBA
01/2023
1AcidsIBA
01/2023
1Desoxycorticosterone (Deoxycorticosterone)IBA
01/2023
1SW033291IBA
01/2023
1EicosanoidsIBA
01/2023
1Mitogen-Activated Protein Kinase 3IBA
01/2023
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2023
1Arachidonic Acid (Vitamin F)IBA
01/2023
1Fatty Acids (Saturated Fatty Acids)IBA
01/2023
1Adenosine Triphosphate (ATP)IBA
12/2022
1Messenger RNA (mRNA)IBA
11/2021
1RNA (Ribonucleic Acid)IBA
11/2021
1C.I. direct red 80IBA
11/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2021
1Dual-Specificity PhosphatasesIBA
01/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2021
1TubulinIBA
05/2020
1poly-N-isopropylacrylamideIBA
01/2019
1ChromatinIBA
01/2019
1Biocompatible Materials (Biomaterials)IBA
01/2019
1polyureaIBA
01/2019
1SaltsIBA
01/2018
1Myosins (Myosin)IBA
01/2018
1Serotonin (5 Hydroxytryptamine)IBA
02/2017
1MonocrotalineIBA
02/2017
1ambrisentanFDA Link
02/2017
1Tryptophan HydroxylaseIBA
02/2017
1Antimalarials (Antimalarial Agents)IBA
01/2016
1ArtesunateIBA
01/2016
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
01/2016
1Tetradecanoylphorbol AcetateIBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Epoprostenol (Prostacyclin)FDA LinkGeneric
11/2014
1Soluble Guanylyl CyclaseIBA
11/2014
1Semaxinib (SU5416)IBA
11/2014
1Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
11/2014
1Endothelin Receptors (Endothelin Receptor)IBA
11/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2014
1tubastatin AIBA
07/2014
1OxysterolsIBA
06/2014
1CholesterolIBA
06/2014
1Apolipoproteins E (ApoE)IBA
06/2014
1CCAAT-Enhancer-Binding ProteinsIBA
06/2014
1Transcription Factors (Transcription Factor)IBA
06/2014
1Ezetimibe (Zetia)FDA Link
06/2014
1Simvastatin (Zocor)FDA LinkGeneric
06/2014
1Antifibrotic AgentsIBA
02/2014
1Lysine (L-Lysine)FDA Link
10/2013

Therapy/Procedure

5Therapeutics
10/2017 - 03/2012
1Injections
01/2019